* A transformative leap beyond PRP therapy, SPSCs utilise the body's own rare regenerative cells to promote deeper and more complete healing

Dubai: Eterna Health, in partnership with leading regenerative medicine expert Dr Adeel Khan, has announced the introduction of a breakthrough therapy based on Small Pluripotent Stem Cells (SPSCs) -- a next-generation advancement that takes regenerative medicine far beyond the scope of Platelet-Rich Plasma (PRP).

PRP therapy has long been valued for stimulating tissue repair through growth factors, yet SPSCs represent a far more advanced approach. Found naturally in adult blood, these stem-like cells are rarer than PRP but significantly more potent, capable not only of signalling repair but also of directly rebuilding damaged tissues -- resulting in deeper and longer-lasting regeneration.

Extracted from a routine blood draw, SPSCs are exceptionally small -- under five micrometres -- and display key pluripotency markers including OCT4, NANOG, SOX2 and SSEA-4, demonstrating their ability to develop into various tissue types. Eterna Health's research laboratories have refined a gentle cold-enrichment process that enables the concentration of between 200 and 500 million viable SPSCs from just 60 millilitres of blood. Their tiny size allows them to circulate freely within the body, unlike larger stem cells that may become lodged in the lungs.

Initial clinical insights point to a strong safety profile for SPSCs, with no evidence of tumour formation and highly encouraging early outcomes. Together, these findings position SPSCs as a revolutionary new tool for regenerative medicine -- setting a new standard for natural cellular repair and rejuvenation.

"PRP gives the body the signal to heal. SPSCs supply the mechanism," stated Dr. Adeel Khan, CEO and Founder of Eterna Health. "By tapping into the body's own regenerative capacity, we can now go beyond signalling and facilitate actual cellular repair and renewal in a safe, effective and natural way."

The new therapy uses the patient's own blood and is minimally manipulated, following the safety frameworks of regulatory agencies like the FDA and the EMA for regenerative medicine. This keeps the treatment biologically compatible and follows regulations, and it helps eliminate the risk of cultured cells or genetically modified stem cells.

Dr. Khan commented, "Safety, science and transparency are the cornerstone of everything we do. Our process is built upon solid biology and clinical standards, and a great respect for patient trust. SPSCs is the next step in the progression of responsible evidence-based regenerative care."

Dr. Adeel Khan Md is a globally recognized authority in regenerative medicine and is well known for his leadership in applied cell therapy. He works with top athletes, longevity researchers, and internationally recognized health organizations to foster the safe and evidence-based use of stem-cell science. He is guiding Eterna Health to bridge the evolving regenerative landscape with clinical and patient-centred research to ensure new regenerative technologies are sound within a clinical context.

Dr. Khan and Eterna Health continue the important global conversation around responsible regenerative medicine that is ethical, and evidence based. The availability of this therapy adds to Eterna Health's position as a leader in regenerative and functional medicine. By integrating academic rigor with patient-centred innovation, the clinic continues to provide accessible, ethical and effective therapies that harness the body's innate ability to heal itself.

source:newsreleases.co.uk